Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors ; volume:51 ; number:4 ; year:2018 ; pages:1982-1995
Cellular physiology and biochemistry ; 51, Heft 4 (2018), 1982-1995
- Creator
-
Kaneko, Yuji
Tuazon, Julian P.
Ji, Xunming
Borlongan, Cesario V.
- DOI
-
10.1159/000495722
- URN
-
urn:nbn:de:101:1-2018121923275771312448
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kaneko, Yuji
- Tuazon, Julian P.
- Ji, Xunming
- Borlongan, Cesario V.
Other Objects (12)
Lack of Pituitary Adenylate Cyclase–Activating Polypeptide (PACAP) Disturbs Callus Formation
Pituitary adenylate cyclase-activating polypeptide expression in peripheral blood mononuclear cells of migraineurs
Zur neuroprotektiven Wirkung des „Pituitary Adenylate Cyclase-Activating Polypeptide" gegenüber toxischen Alzheimer-Amyloid-Peptiden
Charakterisierung eines spezifischen Membranrezeptors für das regulatorische Peptid "Pituitary Adenylate Cyclase Activating Polypeptide" (PACAP)
Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
The Effects of Pituitary Adenylate Cyclase Activating Polypeptide in Renal Ischemia/Reperfusion : A Review
Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in the circulation after sumatriptan
Age-related alterations of articular cartilage in pituitary adenylate cyclase–activating polypeptide (PACAP) gene–deficient mice
Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells
Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine
Untersuchung der Struktur-Funktions-Beziehung des Pituitary Adenylate Cyclase Activating Polypeptide Response Gene 1 (PRG1-IEX-1)
Lack of Pituitary Adenylate Cyclase–Activating Polypeptide (PACAP) Disturbs Callus Formation
Pituitary adenylate cyclase-activating polypeptide expression in peripheral blood mononuclear cells of migraineurs
Zur neuroprotektiven Wirkung des „Pituitary Adenylate Cyclase-Activating Polypeptide" gegenüber toxischen Alzheimer-Amyloid-Peptiden
Charakterisierung eines spezifischen Membranrezeptors für das regulatorische Peptid "Pituitary Adenylate Cyclase Activating Polypeptide" (PACAP)
Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
The Effects of Pituitary Adenylate Cyclase Activating Polypeptide in Renal Ischemia/Reperfusion : A Review
Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in the circulation after sumatriptan
Age-related alterations of articular cartilage in pituitary adenylate cyclase–activating polypeptide (PACAP) gene–deficient mice
Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells
Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine
Untersuchung der Struktur-Funktions-Beziehung des Pituitary Adenylate Cyclase Activating Polypeptide Response Gene 1 (PRG1-IEX-1)
Lack of Pituitary Adenylate Cyclase–Activating Polypeptide (PACAP) Disturbs Callus Formation
Pituitary adenylate cyclase-activating polypeptide expression in peripheral blood mononuclear cells of migraineurs
Zur neuroprotektiven Wirkung des „Pituitary Adenylate Cyclase-Activating Polypeptide" gegenüber toxischen Alzheimer-Amyloid-Peptiden
Charakterisierung eines spezifischen Membranrezeptors für das regulatorische Peptid "Pituitary Adenylate Cyclase Activating Polypeptide" (PACAP)
Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
The Effects of Pituitary Adenylate Cyclase Activating Polypeptide in Renal Ischemia/Reperfusion : A Review
Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in the circulation after sumatriptan
Age-related alterations of articular cartilage in pituitary adenylate cyclase–activating polypeptide (PACAP) gene–deficient mice
Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells
Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine